$224 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 9 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TTOO | Sell | T2 Biosystems, Inc. | $36,835,000 | -0.0% | 2,269,578 | -4.4% | 16.43% | -0.2% |
| PULM | New | Pulmatrix Inc. | $34,637,000 | – | 3,607,996 | +100.0% | 15.45% | – |
| LIFE | New | Atyr Pharma Inc. | $33,854,000 | – | 1,827,992 | +100.0% | 15.10% | – |
| GNCA | Sell | Genocea Biosciences, Inc. | $27,029,000 | +10.9% | 1,968,606 | -4.2% | 12.05% | +10.7% |
| OCUL | Sell | Ocular Therapeutix, Inc. | $25,867,000 | -69.7% | 1,230,009 | -39.4% | 11.54% | -69.7% |
| TRVN | Trevena, Inc. | $23,596,000 | -4.0% | 3,769,280 | 0.0% | 10.52% | -4.2% | |
| FATE | Fate Therapeutics, Inc. | $16,002,000 | +32.3% | 2,473,186 | 0.0% | 7.14% | +32.1% | |
| CERU | Cerulean Pharma Inc | $15,123,000 | -48.9% | 3,287,529 | 0.0% | 6.74% | -49.0% | |
| BINDQ | Bind Therapeutics, Inc. | $11,282,000 | +1.8% | 2,018,253 | 0.0% | 5.03% | +1.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Fate Therapeutics, Inc. | 30 | Q2 2021 | 79.2% |
| Atyr Pharma Inc. | 26 | Q3 2021 | 15.1% |
| Trevena, Inc. | 22 | Q2 2019 | 24.9% |
| Genocea Biosciences, Inc. | 21 | Q1 2019 | 32.5% |
| Selecta Biosciences, Inc. | 20 | Q1 2021 | 39.5% |
| T2 Biosystems, Inc. | 20 | Q2 2019 | 36.1% |
| Dare Bioscience, Inc. | 17 | Q3 2021 | 3.9% |
| Pulmatrix, Inc. | 16 | Q1 2019 | 15.4% |
| Cerulean Pharma Inc | 13 | Q2 2017 | 16.2% |
| Kala Pharmaceuticals, Inc. | 11 | Q1 2020 | 37.1% |
View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2022-03-30 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-12 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-14 |
| 4 | 2020-05-06 |
| 3 | 2020-04-30 |
View Polaris Venture Management Co. V, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.